Stuver R, Horwitz SM, Advani RH, Vose JM, et al. Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma. Br J Haematol 2023 May 22. doi: 10.1111/bjh.18885.
PMID: 37217196